Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
The working group for Surveillance studies in a pandemic (SSiaP) met for the fourth time on 14–15 July 2009, in Stockholm. The final report of that meeting presents the outcomes of the discussions on addressing the challenges for surveillance during a pandemic.